(L to R) Beth Schultz Scott, OD; Vic Noble; and Debra Schaumberg, OD.
​
LEXINGTON, Mass.—Shire (LSE: SHP, NASDAQ: SHPG) has announced an expansion of the pharmaceutical company’s ophthalmics team with the appointments of Vic Noble as head of marketing and Debra Schaumberg, OD, and Beth Schultz Scott, OD, as global medical leads in ophthalmics.

Noble, the company said, has a proven track record developing and launching brands over the last 20 years. She began her career as an IPO analyst and later became a lobbyist in Washington, D.C. for financial firms. She then moved into a marketing career with leading advertising agencies including FCB, Ogilvy and Stein Rogan where she led brand management and developed fully integrated marketing campaigns. VNoble took this experience to the pharmaceutical industry where she managed major marketing campaigns for companies including Johnson & Johnson (Remicade, Topamax, and cancer.com) and Astra Zeneca (Crestor).

Noble joined Shire in April 2008 and has served in marketing leadership roles for Shire’s GI and Neuroscience Business Units and, most recently, led consumer marketing strategy for the ophthalmics business unit. In her current role, she will lead all marketing activities related to Shire’s Ophthalmics portfolio, including its investigational candidate for dry eye disease, lifitegrast.

Noble graduated from UC Berkeley with a degree in Business and Political Science. In 2015, he was inducted into the Direct-to-Consumer Marketing Hall of Fame.

Schaumberg, ScD, OD, MPH, is an internationally renowned expert in epidemiology with a focus on eye disease. Dr. Schaumberg’s extensive clinical and academic experience includes nearly 20 years as a faculty member at Harvard Medical School in Ophthalmology and Medicine. She is an adjunct professor of Epidemiology at the Harvard School of Public Health, adjunct professor of Ophthalmology at the University of Utah School of Medicine and fellow of the American College of Epidemiology and the American Academy of Optometry.

In her new role with Shire, Dr. Schaumberg serves as a lead for U.S. and international medical affairs activities for ophthalmics, focusing on professional education and data generation.

Dr. Schaumberg received her OD from the Illinois College of Optometry, MPH from the Johns Hopkins School of Hygiene and Public Health, and ScD from the Harvard School of Public Health, with a concentration in genetic/molecular epidemiology.

Schultz Scott, OD, MS BIO is an expert in eyecare whose career has spanned clinical practice, academia and industry. Previously, Dr. Schultz Scott held leadership positions in regulatory affairs and global medical affairs for health care companies focusing on eyecare.

She has held academic positions including faculty member at the Pennsylvania College of Optometry as well as founding member of the Hogeschool van Utrecht School of Optometry and Eye Care Clinic in The Netherlands. In her new role with Shire, Dr. Schultz Scott serves as a lead for U.S. and international medical affairs activities for ophthalmics, with an emphasis on lifecycle product management.

Dr. Schultz Scott received her OD from the Pennsylvania College of Optometry and her Masters in Clinical Pharmacology at Thomas Jefferson University with a research emphasis in ocular oncology.